복강경하 부인과 수술 시장 규모, 점유율 및 동향 분석 보고서 : 수술 유형별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Laparoscopic Gynecological Procedures Market Summary

The global laparoscopic gynecological procedures market size was valued at USD 20.5 billion in 2025 and is projected to grow from USD 21.2 billion in 2026 to USD 26.1 billion by 2033, at a CAGR of 3.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 50.2% in 2025.

Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for shorter recovery times and reduced scarring; the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis; and technological advancements, including robotic-assisted surgery.

Moreover, surgical robots are driving innovation in the laparoscopic gynecological procedures industry by enabling enhanced precision, reproducibility, and access in complex pelvic surgeries. Advanced systems such as the da Vinci and Senhance platforms are equipped with wristed instruments, high-definition 3D visualization, and motion scaling, which enable gynecologic surgeons to perform intricate procedures, including endometriosis excision and myomectomy, with enhanced control and minimal invasiveness. For instance, the new study published by Intuitive Surgical in April 2025 highlights that robotic-assisted surgery (RAS) increases access to minimally invasive care, especially in underserved "medical deserts," by overcoming barriers such as limited surgeon training and hospital infrastructure. Hospitals adopting RAS saw higher rates of minimally invasive surgery and expanded access across diverse patient groups, improving patient outcomes. These platforms also accelerate innovation through the integration of digital capabilities, such as real-time analytics, AI-assisted image guidance, and feedback, which collectively improve surgical planning and intraoperative decision-making. Furthermore, the ability of robotic platforms to standardize techniques across varying skill levels is also transforming training and credentialing models, making complex laparoscopic procedures more widely accessible.

The demand for minimally invasive laparoscopic techniques in gynecology is further accelerated by physician training trends and technology integration. Gynecologists are increasingly opting for laparoscopic fellowships and simulation-based training platforms to improve laparoscopic skills, especially for procedures such as total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), and laparoscopic ovarian cystectomy. Market players are responding to this demand with advanced education programs. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, launched an AI-powered laparoscopic skills training platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This platform aims to enhance surgical training by providing surgeons with real-time feedback and objective performance metrics. The AI analyzes surgical techniques, offering personalized guidance to improve skills and accelerate learning. The platform's features include objective assessment of surgical performance, personalized feedback, and opportunities for repeated practice in a simulated environment, ultimately aimed at improving surgical outcomes. This innovation represents a significant advancement in surgical education and training, leveraging AI to optimize the learning process for surgeons. Such initiatives are further enhancing the laparoscopic procedure, offering capabilities of healthcare providers, further increasing the preference towards minimally invasive procedures over traditional open procedures.

The increasing prevalence of gynecological disorders such as endometriosis and uterine fibroids is significantly fueling the demand for laparoscopic interventions. Laparoscopy is increasingly preferred for the diagnosis and treatment of these conditions due to its ability to offer targeted, minimally invasive management with lower postoperative complications and faster recovery compared to open surgery. According to the World Health Organization (WHO), around 10% or approximately 190 million reproductive-age individuals globally are affected by endometriosis. Similarly, a study published in Springer Nature in May 2023 analyzed global trends in uterine fibroids from 1990 to 2019, revealing a 67% increase in incidence, 79% in prevalence, and 77% in years lived with disability. Age-period-cohort modeling indicated rising burdens, especially in low- and middle-Socio-demographic Index regions, with peak incidence at ages 35-44. This rise in gynecological procedures significantly contributesto the rise in demand for advanced laparoscopic procedures.

Moreover, the trend toward early-stage detection of gynecological conditions, driven by increased awareness and access to gynecological care, has expanded the pool of eligible patients for laparoscopic gynecological procedures. This shift is pushing healthcare facilities to invest in laparoscopic systems and training. Manufacturers of laparoscopic instruments and energy devices are capitalizing on this surge by offering disease-specific toolkits, such as fibroid morcellators and endometriosis resection kits, which are increasing procedural efficiency.

Global Laparoscopic Gynecological Procedures Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global laparoscopic gynecological procedures market report based on procedure, end-use, and region:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Laparoscopic Hysterectomy
• Laparoscopic Adnexal
• Laparoscopic Endometrial Excision
• Laparoscopic Diagnostic Procedures
• Laparoscopic Myomectomy
• Laparoscopic Colpopexy
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Laparoscopic Gynecological Procedures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Laparoscopic Gynecological Procedures Procedure Market Movement Analysis
• 4.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
• 4.4. Laparoscopic Hysterectomy
  • 4.4.1. Laparoscopic Hysterectomy market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Laparoscopic Adnexal
  • 4.5.1. Laparoscopic Adnexal market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Laparoscopic Endometrial Excision
  • 4.6.1. Laparoscopic Endometrial Excision market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Laparoscopic Diagnostic Procedures
  • 4.7.1. Laparoscopic Diagnostic Procedures market estimates and forecasts 2021 to 2033 (USD Million)
• 4.8. Laparoscopic Myomectomy
  • 4.8.1. Laparoscopic Myomectomy market estimates and forecasts 2021 to 2033 (USD Million)
• 4.9. Laparoscopic Colpopexy
  • 4.9.1. Laparoscopic Colpopexy market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Laparoscopic Gynecological Procedures End Use Market Movement Analysis
• 5.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals' market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Clinics
  • 5.5.1. Clinics market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Ambulatory Surgery Centers market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis By Procedure, End Use

• 6.1. Regional Market Share Analysis, 2026 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement structure
    • 6.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement structure
    • 6.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement structure
    • 6.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement structure
    • 6.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement structure
    • 6.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement structure
    • 6.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework
    • 6.6.4.4. Reimbursement structure
    • 6.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework
    • 6.6.5.4. Reimbursement structure
    • 6.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework
    • 6.6.6.4. Reimbursement structure
    • 6.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework
    • 6.6.7.4. Reimbursement structure
    • 6.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework
    • 6.6.8.4. Reimbursement structure
    • 6.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement structure
    • 6.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement structure
    • 6.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement structure
    • 6.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement structure
    • 6.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement structure
    • 6.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement structure
    • 6.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement structure
    • 6.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement structure
    • 6.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement structure
    • 6.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement structure
    • 6.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework
    • 6.9.3.4. Reimbursement structure
    • 6.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework
    • 6.9.4.4. Reimbursement structure
    • 6.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2026
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
• 7.6. Company Profiles
  • 7.6.1. Medtronic
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Stryker
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. Karl Storz SE & CO. Kg
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Johnson and Johnson
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Olympus Corporation
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. CONMED Corporation
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. B. Braun SE
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. CooperCompanies
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Richard Wolf GmbH
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. Microline Surgical
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives
  • 7.6.11. Welfare Medical Ltd.
    • 7.6.11.1. Company overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Product benchmarking
    • 7.6.11.4. Strategic initiatives
  • 7.6.12. Intuitive Surgical
    • 7.6.12.1. Company overview
    • 7.6.12.2. Financial performance
    • 7.6.12.3. Product benchmarking
    • 7.6.12.4. Strategic initiatives
  • 7.6.13. Shenzhen Mindray Bio Medical Electronics Co., Ltd.
    • 7.6.13.1. Company overview
    • 7.6.13.2. Financial performance
    • 7.6.13.3. Product benchmarking
    • 7.6.13.4. Strategic initiatives